PEN Penumbra, Inc.
$319.12 -0.28%
US Stock · Health Care
RSI (14) · 30 / 70 bands
MACD (12, 26, 9)
Solid = close · dashed = 50-day MA · bars = volume. Toggle Bollinger / RSI / MACD. Point at or drag across the chart to read a day. EOD data.
1D
-0.28%
YTD
+2.60%
P/E
80.38
P/B
8.53
ROE
10.4%
Div yield
—
Beta
0.16
Market cap
$12.6B
RSI (14)
45
Next earnings
—
Same sector · Health Care
Compare PEN with NVO and JNJ →Follow PEN in the AlfaCat app
Watchlist, price and earnings alerts, the chart offline. Free, no account, no ads.
The economy behind it · United States
Economy this week on BullDozer →GDP, % on year
2.1
Q3 2026
Inflation, %
3.7
Sep 2026
Unemployment, %
3.9
Oct 2026
10-yr yield, %
5.13
Oct 2026
From BullDozer, our sister site for country statistics (open sources: OECD, IMF, Eurostat, ILO). Full United States profile →
Previous session
close of Nov 20, 2026 · EOD, no live order bookOpen
$319.91
Close
$319.12
Day high
$320.32
Day low
$319.02
Volume
205K
Latest headlines
Boston Scientific Prices $7.66 Billion in Notes to Fund Penumbra Acquisition
Yahoo Finance · Nov 20
Penumbra (PEN) Stock Faces Q3 Earnings Valuation Scrutiny
Yahoo Finance · Oct 31
Penumbra: Q3 Earnings Snapshot
Yahoo Finance · Oct 29
Penumbra, Inc. Reports Third Quarter 2026 Financial Results
Yahoo Finance · Oct 29
Penumbra's CAVT Technology Receives FDA Clearance for the Treatment of Deep Vein Thrombosis (DVT)
Yahoo Finance · Oct 20
Penumbra (PEN) Clinical Data Puts Its Valuation Back In Focus
Yahoo Finance · Oct 8
Headlines via Yahoo Finance · links open the source · not an endorsement.
Recent SEC filings
10-Q Oct 29, 2026 View → 8-K Oct 29, 2026 View → 10-Q Jul 30, 2026 View → 8-K Jul 30, 2026 View → 8-K Jun 22, 2026 View →
Source: SEC EDGAR · opens the official filing.
Research & reports
External resources — availability and opinions are theirs, not ours.
This is reference data for your own analysis — not a recommendation to buy or sell PEN. Try it in the Lab to size a position and see the risk.